Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006
- PMID: 21817948
- DOI: 10.1097/INF.0b013e31822e68e6
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006
Abstract
Background: Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract disease among young children in the United States. RSV-associated hospitalization increased among children in the United States during 1980 through 1996. In this study, we updated national estimates of RSV hospitalization rates among US children through 2006.
Methods: We conducted a retrospective analysis of hospital discharges for lower respiratory tract illness (LRTI) in children <5 years old from the National Hospital Discharge Survey. LRTI hospitalizations were identified by using International Classification of Diseases, Ninth Revision, Clinical Modification codes. RSV-coded hospitalizations were International Classification of Diseases, Ninth Revision, Clinical Modification codes 466.11, 480.1, and 079.6. RSV-associated hospitalizations were the sum of RSV-coded hospitalizations and a proportion of hospitalizations coded as bronchiolitis and pneumonia during the RSV season.
Results: RSV-coded hospitalizations accounted for 24% of an estimated 5.5 million LRTI hospitalizations among children <5 years of age during the 10 study years, 1997-2006. The RSV-coded hospitalization rate in infants <1 year old was 26.0 per 1000, with no significant difference between study years. The hospitalization rate was highest among infants <3 months old (48.9 per 1000), followed by infants 3 to 5 months old (28.4 per 1000), and lower among those >1 year old (1.8 per 1000). An estimated 132,000 to 172,000 RSV-associated hospitalizations occurred annually in children <5 years of age.
Conclusion: RSV hospitalization rates remained steady during 1997 to 2006 and were a substantial burden in the United States, especially among infants and young children. A safe and effective RSV vaccine is needed.
Similar articles
-
Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.Pediatr Infect Dis J. 2006 Dec;25(12):1116-22. doi: 10.1097/01.inf.0000245104.26996.57. Pediatr Infect Dis J. 2006. PMID: 17133156
-
Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida.Pediatr Infect Dis J. 2008 Jun;27(6):512-8. doi: 10.1097/INF.0b013e318168daf1. Pediatr Infect Dis J. 2008. PMID: 18449062
-
Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii.Pediatr Infect Dis J. 2007 Dec;26(12):1081-8. doi: 10.1097/INF.0b013e31812e62c2. Pediatr Infect Dis J. 2007. PMID: 18043442
-
Better newborn vitamin D status lowers RSV-associated bronchiolitis in infants.Nutr Rev. 2012 Sep;70(9):548-52. doi: 10.1111/j.1753-4887.2012.00517.x. Epub 2012 Aug 17. Nutr Rev. 2012. PMID: 22946854 Review.
-
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden.J Infect Dis. 1999 Jan;179(1):25-30. doi: 10.1086/314567. J Infect Dis. 1999. PMID: 9841818 Review.
Cited by
-
Viral etiology of severe lower respiratory tract infections in SARS-CoV-2 negative hospitalized patients during the COVID-19 pandemic in Kuwait.Heliyon. 2024 Apr 17;10(8):e29855. doi: 10.1016/j.heliyon.2024.e29855. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38681623 Free PMC article.
-
Cooperative interaction of interferon regulatory factor -1 and bromodomain-containing protein 4 on RNA polymerase activation for intrinsic innate immunity.Front Immunol. 2024 Mar 27;15:1366235. doi: 10.3389/fimmu.2024.1366235. eCollection 2024. Front Immunol. 2024. PMID: 38601157 Free PMC article.
-
Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy.Ital J Pediatr. 2024 Mar 25;50(1):57. doi: 10.1186/s13052-024-01628-7. Ital J Pediatr. 2024. PMID: 38528616 Free PMC article.
-
An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort study.Ital J Pediatr. 2024 Mar 25;50(1):56. doi: 10.1186/s13052-024-01627-8. Ital J Pediatr. 2024. PMID: 38528568 Free PMC article.
-
Characteristics and Outcomes of Pregnant Women Hospitalized With Laboratory-Confirmed Respiratory Syncytial Virus Before and During the COVID-19 Pandemic.Open Forum Infect Dis. 2024 Jan 31;11(3):ofae042. doi: 10.1093/ofid/ofae042. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38524226 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical